Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?

To: C Wright who wrote (24)	1/25/1999 12:52:00 PM
From: C Wright	Respond to of 447

News ... biz.yahoo.com (eom)

To: C Wright who wrote (24)	1/25/1999 2:39:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 447

Carol!! Thanks for the lead. I'll take a look, but you know me and non-bio stuff. Yes, OSIP has tripped my trigger..... it's my number three holding. No, my opinion hasn't changed..... I look forward to their taking the lead, together with SUGN, in the realm of angiogenesis. Pfizer's transition to expanded trials is not recognized as significant yet, IMO, due to paranoia about third-tier biotech. Haven't listened to VCAL (?) audio of the beltway II presentation. Could someone who attended or listened please summarize? Looks like it went well. Rick